Ranbaxy venture wins $133-m HIV drug supply order in S. Africa

21 Dec 2010 Evaluate

Ranbaxy Laboratories South Africa-based joint venture, Sonke Pharmaceuticals, has won Rand $133 million order in that country for supplying anti-retroviral (ARV) drugs for prevention and treatment of AIDS over the next two years.

Sonke Pharmaceuticals is a joint venture between Ranbaxy Pharmaceuticals and Community Investment Holding is the second largest local supplier of generic ARV medication in South Africa. The medicines will be manufactured in South Africa and at Ranbaxy facilities in India.crackcrack

Peers
Company Name CMP
Sun Pharma Inds. 1749.80
Dr. Reddys Lab 1264.00
Cipla 1495.35
Zydus Lifesciences 914.45
Lupin 2105.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×